Tokyo, Nov 4, 2011 (JCN) - Asahi Kasei Pharma will be setting up a new research complex in its Pharmaceutical Research Center in Shizuoka, Japan, to advance research on new drugs. The facility is slated for operation in fiscal 2013.
The research facility construction is under the company's "For Tomorrow 2015" strategic initiative, one of the key objectives of which is the expansion of Asahi Kasei Group's healthcare operations. Asahi Kasei Pharma, whose research activities in the pharmaceutical field focused on successively generating new drugs targeting unmet medical needs, decided to enhance its research infrastructure to enable effective R&D by constructing a new advanced complex.
Apart from its state-of-the-art experimental apparatus and facilities, the complex will provide an environment to facilitate closer collaboration and coordination among researchers.
Copyright © 2013 JCN. All rights reserved. A division of Japan Corporate News Network KK.
 Company Profile |  Print |  Alerts
|
 |
|
Asahi Kasei Pharma Applies for Approval of Famvir for Additional Indication
(Feb 7, 2012)
|
|
|
Asahi Kasei Pharma Launches Flivas in South Korea
(Jan 13, 2012)
|
|
|
Asahi Kasei Pharma Launches Osteoporosis Drug in Japan
(Dec 6, 2011)
|
|
|
Artisan Pharma Now Wholly Owned Subsidiary of Asahi Kasei
(Nov 9, 2011)
|
|
|
Asahi Kasei to Build New Pharmaceutical Research Complex
(Nov 4, 2011)
|
|
|
Asahi Kasei Licenses Zosano Pharma Microprojection Technology for Teribone Hormone
(Oct 17, 2011)
|
|
|
Asahi Kasei Pharma Licenses XIAFLEX from Auxilium Pharmaceuticals
(Mar 23, 2011)
|
|
|
Asahi Kasei Targets Osteoporosis in Japan
(Oct 26, 2010)
|
|
|
Asahi Kasei Pharma Licenses Bisphosphonate Zoledronic Acid for Japan
(June 15, 2010)
|
|
|
Asahi Kasei Licenses Anti-glaucoma Drug to Altheos
(Apr 9, 2010)
|
|
|
|
|
|
|
Fujifilm Initiates Phase I Clinical Trial in Japan for Anticancer Agent FF-10501 (June 7, 2013)
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
More Drugs & OTC news...
|
|
|
|
|
|
Fujifilm Initiates Phase I Clinical Trial in Japan for Anticancer Agent FF-10501 (June 7, 2013)
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
More Medical news...
|
|
